Skip to main content
Clinical Trials/NCT06514170
NCT06514170
Recruiting
Not Applicable

Assessment of Gastrointestinal Dysfunction Through GIDS Scale and Intestinal Damage Biomarkers in Critically Ill Patients Undergoing Aortic Surgery and Its Association With Clinical Outcomes.

Instituto Nacional de Cardiologia Ignacio Chavez1 site in 1 country114 target enrollmentJuly 23, 2024

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Aortic Aneurysm
Sponsor
Instituto Nacional de Cardiologia Ignacio Chavez
Enrollment
114
Locations
1
Primary Endpoint
Calories delivered daily enterally and/or parenterally
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

The goal of this observational study is to determine the association of gastrointestinal dysfunction through the Gastrointestinal Dysfunction Scale (GIDS) tool and serum concentrations of citrulline and Intestinal fatty-acid binding protein (I-FABP) with primary [calories received, protein received, parenteral nutrition requirement and 28-day mortality in the intensive care unit (ICU)] and secondary (development of pneumonia, surgical and cardiovascular complications in the ICU, length of hospital and ICU stay, duration of mechanical ventilation) clinical outcomes in critically ill patients undergoing aortic surgery.

Detailed Description

The treatment of choice for various cardiovascular diseases often involves cardiac surgery, including aortic surgery, which is performed to correct conditions related to this major vessel, such as aneurysms, stenosis, aortic dissections, as well as issues affecting the aortic valve. With the increasing prevalence of non-communicable chronic diseases, a 46% increase in demand for cardiac surgeries is projected by 2025. The post-surgical period, commonly in the intensive care unit (ICU), increases the risk of complications, especially in patients with pre-existing risk factors. In this regard, gastrointestinal (GI) dysfunction affects up to 63% of patients, being associated with complications and a mortality rate of 55% to 60%. Early detection of GI dysfunction allows for the implementation of management strategies. Additionally, the administration of appropriate nutritional therapy is essential for recovery, and GI dysfunction may limit nutrient absorption. Inadequate caloric intake has been linked to increased morbidity and mortality. Tools such as GIDS (Gastrointestinal Dysfunction Scale) and biomarkers like citrulline and I-FABP enable early evaluation of GI function, advancing monitoring and management. Identifying changes before serious complications arise allows for early and personalized interventions. Early detection not only prevents complications and improves quality of life but may also reduce mortality. This research project aims to address these gaps by early assessing GI dysfunction in post-aortic surgery patients. Utilizing the GIDS tool and biomarkers such as citrulline and I-FABP, the goal is to identify GI dysfunction early and its impact on nutrition administration.

Registry
clinicaltrials.gov
Start Date
July 23, 2024
End Date
June 2026
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
Instituto Nacional de Cardiologia Ignacio Chavez
Responsible Party
Principal Investigator
Principal Investigator

Gustavo Rojas Velasco

Head of the Cardiovascular Intensive Care Unit

Instituto Nacional de Cardiologia Ignacio Chavez

Eligibility Criteria

Inclusion Criteria

  • 18 years of age or older.
  • Patients after surgical interventions (elective or urgency) on the aorta with cardiopulmonary bypass.
  • Invasive mechanical ventilation expected to be required more than 48 hours.
  • Signed informed consent.

Exclusion Criteria

  • Patients under mechanical ventilation with pre-existing gastrointestinal issues.
  • Diagnosis of adult congenital heart disease.
  • Ongoing pregnancy or lactation period.
  • Simultaneous participation in another clinical study involving experimental therapy.
  • Presence of chronic intestinal disease.
  • Previous gastrointestinal conditions detected during nutritional screening.

Outcomes

Primary Outcomes

Calories delivered daily enterally and/or parenterally

Time Frame: Day 0 to day 7

Percentage representation of prescribed calories delivered daily via enteral and/or parenteral routes.

Protein delivered daily enterally and/or parenterally

Time Frame: Day 0 to day 7

Daily administration of protein (in grams) through enteral and/or parenteral routes.

Secondary Outcomes

  • ICU readmission rate(90 days)
  • ICU length of stay(90 days)
  • Duration of mechanical ventilation(90 days)
  • Percentage of repeated operations(90 days)
  • Incidence rate of hospital-acquired infections(7 days)
  • Hospital length of stay(90 days)
  • Parenteral nutrition requirement(Day 0 to day 7)
  • 28-day mortality in the ICU(28 days)

Study Sites (1)

Loading locations...

Similar Trials